Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
What impressed me was the good clinical shape of the inpatient who had received the Interferon B. First treated case that we've seen. "Einmal ist keinmal", as the Germans like to say, but still....encouraging!
https://www.bbc.co.uk/iplayer/episode/m000jldv/south-today-evening-news-28052020
This is the link to the BBC South item on SNG, if anyone is interested.
SNG was featured pretty extensively on local Southampton BBC TV news this lunchtime & afternoon. Home patients are being encouraged to contact the clinical team on https://www.covidtrialathome.com to arrange treatment. Views included an interview with one hospital patient who has been treated, & now looks pretty perky!
Does anyone know how home testing is supposed to work? The Govt like to centralise & control everything - e.g. supply of PPE, antigen testing, NHS before Care homes etc - which is why our response to Covid has lagged behind Germany/Korea etc. I doubt that they will allow unrestricted sale of home AB testing on the open market - they will want to direct where it gets used & obtain notification of the results. GP's will also need to be notified of the results. So use restricted to Govt "testers", presumably.
I just wonder if the dead hand of Govt is going to foul this up for PI's by limiting the market. Or am I being thick?
I remember Holgate, from when he was an SHO at Southampton General. My dept did certain scans, & sent the images & reports down to the wards. Close around 5.00 PM. Holgate was one of the few to visit us occasionally around this time to discuss the results. Thoughtful sort of chap in an understated way. Never would have thought that he would go so far! Helps if you know the people you're invested with, I find.
I agree. But don't worry about the shorters - they're having a field day! In fact, if they don't desist, (and they won't!) I could imagine a concerted move to close the markets down. If it happens it will be sudden & without warning. Don't leave it too late if you're tracking a purchase!
Aim-traded Bango (BGO:69p), a provider of a state-of-the-art mobile payment platform enabling smartphone users to charge purchases made in app stores straight to their mobile phone account, is benefiting from the global lockdown following the outbreak of Covid-19.
With millions of people stuck at home and schools closures across the world, appstore and in gaming spend could ramp up sharply as has previously been the case during holidays and festivals. Bango is leveraged to an uptick in business across multiple territories including Japan where physical goods and delivery services can be paid for via its platform, too. The Covid-19 lockdown could be in force for months, thus forcing marketers to spend more on their campaigns, which in turn is good news for Bango’s data monetisation business. Chief executive Paul Larbey notes that consumer spending on online services and entertainment has been increasing in countries where there are “stay at home” policies.
Bango’s end user spend (EUS) doubled for the fifth consecutive year to £1.1bn, and the company moved into cash profit last year. Alongside the annual results, Bango announced the launch of carrier billing payment services with Hatch, the US monthly subscription-based 5G games streaming platform, adding further to its recurring revenue stream having agreed a similar deal for the monthly subscription-based YouTube TV package.
So, with the benefit of stable operating costs and a platform that has been tested to process payments of £25bn, Bango’s operational gearing should really kick in this year. Also, some large licenses “worth seven figures” that were due to be signed at the end of 2019, will now be higher value when they are signed off in the first half, adding weight to finnCap’s 2020 forecast of a 58 per cent revenue hike to £14.7m. On this basis, expect cash profit to surge from £400,000 to £3.4m and produce pre-tax profit of £0.9m. Bango can fund its business internally as it has a cash rich balance sheet and 2020 operating cash flow is forecast to treble to £2.5m.
True, the market crash has wiped out the 40 per cent paper profit since my November article (‘Bango gaining momentum, 25 November 2019). However, the business could be making £10m of annualised cash profit on revenue of £20m next year, a level of profitability that a market capitalisation of £48m fails to reflect. In a more benign stock market, the share price could double. Buy.
Or "Ante auroram tenebrae maximae sunt" has a nice ring to it, Lucretius. There seem to be two views going round the market - one is that SP values are depressed directly due to Covid-19, the other is that the is a necessary correction triggered by Covid. As long as the second holds, the markets will trade. But if one exchange decides to quarantine its shares, the others will follow quickly. Its not just about business, it's about the values of peoples pensions.
This Covid is going to be a Biblical event, and the only thing that works, to some degree, is mass quarantining. Laissez-faire, as per the UK Govt, is just a grim joke. An unfortunate moment in our history, to be ruled by a bunch of blithering incompetents. The Europeans have got a better handle on things. The result is that, in the UK, we could see a higher spike, but it will burn out more quickly, as per Spanish flu, where epidemics in big American cities typically lasted around 1 month, if you read the public health accounts.......... but again, WTFDIK!
Covid-19 effectively presses the reset button on the EUA sale negotiations, IMO - I doubt we will hear anything soon. For those waiting to purchase other shares currently in free-fall, my concern is that stock markets around the world may close down - we are seeing the first step taken this morning with a ban on shorting proposed in some quarters. People intending to buy in at these record low levels should possibly not wait too long.
There's no bottom to this market. At some point the Govt is going to have to intervene. Billions are being wiped off the value of pensions, for one thing. Not doom-mongering - just a realist. A general share suspension would provide a safe haven until the situation stabilises.
Not deramping, and I'm in for a few thou, but things operate differently over there, and it's worth remembering that.
Actually hoping for a few discounted NN shares as part of the settlement - if you can't beat them.....!
If you want to do business with Russia,you have to let them screw you over, not the other way round. It's just the way things work over there. No bunch of Western capitalists is going to be permitted to plunder Russian Palladium deposits and not give back into the system. It would be an insult to them if it wasn't totally naive and laughable. But you will be permitted to make some kind of a profit - they tend to invest abroad rather than in their own country (no prizes for guessing why!) so they don't want to totally discourage inward investment. Just look on it as a tax. Plus, to drunkinftl - Russians are great people - outgoing, expansive & full of humour & melancholia in equal proportions. Don't understand them , but always fun to be around. And things are slowly changing at ground level. All governments suffer from corruption to some degree, but the Russian folk are particularly badly served.
I am sure you are right - NN want this asset, if only to mothball it, possibly, in order to keep the price high. NN effectively control the world price of Palladium, and they are not going to permit any independent operator in Russia compete with them on price. It's inconceivable. And for NN read Abramovich, his cronies and their Kremlin backers. Abramovich is always perfectly aligned with the Kremlin.
But NN will only want to pay a minimum price, and can lean on the EUA BOD in various ways - by keeping other buyers out of the market, for instance. Remember, no business in Russia flourishes unless it is permitted to do so.
Hence the BOD are keeping the sale at arms length, using the banks. I really doubt that the BOD - excellent people with extensive experience - lack knowledge regarding the value of the Palladium, mining operation & potential buyers, so why pay a fat success fee to the two banks? What skills do they bring to the party that the BOD lack? But the banks have enough independent influence to resist any power moves on this valuable asset - that is the point of the "added value" that they bring. The BOD - Russian citizens - have no power in Putin's Russia. This is how business at the highest level functions over there. It's totally corrupt. The more that the Kremlin power-brokers take for themselves, the less for the little guy.
I could go on at length - consider quotas. OK, so you have Palladium in the ground - but unless you get allocated a reasonable mining quota - how are you going to monetise it? And who decides how the quotas are divided out? Impartial civil servants? Do me a favour!
The danger in the current situation is that the small shareholder is going to get sold down the river, in favour of NN & their `Kremlin supporters. But by involving the two banks the BOD have reinforced their position considerably - good for them!
My guess - NN will be the buyer, but at a fairer market price than it would have wanted to pay.
Interesting times!
I'm guessing there's a bidding war going on behind the scene, but it's difficult to imagine Norilsk letting this one go, if they really want it. Not only a top Palladium producer, but also a major purchaser of Palladium from other sources, to regulate global supply & price, and already established in the area, so synergies are possible. But the Chinese will certainly be looking to obtain their own secure supply, free of global fluctuations in price.
So one possible outcome is an exchange of EUA shares for Norilsk shares, possibly with some cash thrown in. Preferably not too high a proportion of cash, in view of possible CGT liabilities! Either way, the little guy wins, it seems.
I'm out (pretty much), but good luck with the BOD guys - all LTH's deserve it after the way you've been treated by this bunch. Total lack of commitment.
IMHO they will possibly hope to consolidate around the 10p mark, which will give them the headroom for a fund-raising dilution. Unless they get their act together the SP will slide from there. To be fair to VAL, they have always said that they need partners, to bring their (promising) products to market. They've just been spinning their wheels, waiting for a good Samaritan. Expect more of the same.
It's a combi-trial with an established long-acting bronchodilator in COPD. VRP are trying to establish a niche role for Ensifentrine. I would expect results, consequentially, to be a bit nuanced. Major shareholders may need a bit of time to digest them.
Sold out of ABC on 20/12 - mistimed as usual - because it seemed overvalued, & I fear the SP will drift down as we enter a volatile period ahead.
But I rate ABC highly, & will look to buy back in, in a few months, hopefully.
Don't want to be a party pooper, but I'm out of this nightmare completely now, and never felt better! Sold most for a modest profit before the Ph3 results, as mentioned in an earlier post, but, greed prevailing, kept some back. So I guess a loss overall, but I don't care. It's been a learning experience!
Best of luck guys (& gals). Remember, the SP is totally unsupported right now, other than by Ken's dodgy data, which he will put before the FDA. This data was never intended to support an application of this type, and my guess it has a slim to non-existent chance of success. Ken would not have tried to pull a stunt like this in his GSK days.
After that it's curtains - no marketable product, and no money left. And no-one mug enough to take on a totally un-researched product. The only mugs in this game are the bozos on the BOD, & people like me who stuck wth it too long, when their better instincts were telling them otherwise. .
A shame - it could all have been so different. There's just a chance that DS contains an unknown vasoactive compound - I still partly believe it, but this lot are never going to research it. They just want to flog it off on the back of an FDA approval.
So my last posting on this BB. I'm off. GLA.